Adaptive Biotechnologies Corp ($ADPT)
Filing Information
| Accession Number | 0001780664-26-000030 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 24, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
145,512
Total Value
$1,172,067.76
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President and COO | Common Stock | โ | Apr 22, 2026 | Exercise/Conversion | 14,722 | $8.46 | $124,548.12 | 409,868 | Direct | โ | View Details | |
President and COO | Common Stock | โ | Apr 22, 2026 | Sale | 19,060 | $14.13 | $269,317.80 | 390,808 | Direct | โ | View Details | |
President and COO | Common Stock | โ | Apr 23, 2026 | Exercise/Conversion | 14,722 | $8.46 | $124,548.12 | 405,530 | Direct | โ | View Details | |
President and COO | Common Stock | โ | Apr 23, 2026 | Sale | 19,060 | $13.74 | $261,884.40 | 386,470 | Direct | โ | View Details | |
President and COO | Common Stock | โ | Apr 24, 2026 | Exercise/Conversion | 14,722 | $8.46 | $124,548.12 | 401,192 | Direct | โ | View Details | |
President and COO | Common Stock | โ | Apr 24, 2026 | Sale | 19,060 | $14.02 | $267,221.20 | 382,132 | Direct | โ | View Details | |
President and COO | Stock Option (right to buy) | Derivative | Apr 22, 2026 | Exercise/Conversion | 14,722 | $0.00 | $0.00 | 89,882 | Direct | โ | View Details | |
President and COO | Stock Option (right to buy) | Derivative | Apr 23, 2026 | Exercise/Conversion | 14,722 | $0.00 | $0.00 | 75,160 | Direct | โ | View Details | |
President and COO | Stock Option (right to buy) | Derivative | Apr 24, 2026 | Exercise/Conversion | 14,722 | $0.00 | $0.00 | 60,438 | Direct | โ | View Details |